AKT1 and neoplasm: Furthermore, a meta-analysis of eight datasets, with different subgroups based on clinical parameters such as tumor size and Alpha-fetoprotein (AFP) levels, showed that subclass S2 was characterized by AKT activation in combination with MYC [30,31].